Kyle Dempsey - Dec 10, 2021 Form 4 Insider Report for OptiNose, Inc. (OPTN)

Role
Director
Signature
/s/ Anthony Krick, Attorney-in-Fact
Stock symbol
OPTN
Transactions as of
Dec 10, 2021
Transactions value $
$0
Form type
4
Date filed
12/13/2021, 02:55 PM
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPTN Stock Option (Right to Buy) Award $0 +28.9K $0.00 28.9K Dec 10, 2021 Common Stock 28.9K $1.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a three-year period commencing on December 10, 2021. Thirty-three percent (33%) of the option vests and becomes exercisable on December 10, 2022, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer.